Endogenous heparin - A protective marker in patients with myocardial infarction

Coronary Artery Disease

Volumn 13, Issue 8, 2002, Pages 423-426

  Władysław, Sinkiewicz ^a,b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Provincial Hospital   (Poland)

Author keywords

Endogenous heparin; Immunoglobulin E; Myocardial infarction; TAT complexes

Indexed keywords

HEPARIN; IMMUNOGLOBULIN E; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HEART PROTECTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTITHROMBIN III; BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE HYDROLASES; PROTECTIVE AGENTS; STATISTICS; TREATMENT OUTCOME;

EID: 0036968508     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200212000-00007     Document Type: Article

References (21)

1. Szczeklik A, Śladek K, Szczerba A, Dropiński J. Serum immunoglobulin E response to myocardial infarction. Circulation 1988; 77:1245-1249.
2. Sinkiewicz W, Zbikowska M, Romański B, Hoffmann A. IgE serum concentration and activity of eosinophil measured by eosinophil cation protein serum concentration in patients with recent myocardial infarction and patients with angina pectoris. J Am Coll Cardiol 1998; 3(Suppl C):5.
3. Szczeklik A, Dropiński J, Góra P. Serum immunoglobulin E and sudden cardiac arrest during myocardial infarction. Coronary Artery Dis 1993; 4:1029-1032.
4. Langer R, Criqui MH, Feigelson HS, McCann TJ, Hamburger RN. IgE predicts non-fatal myocardial infarction in men. J Clin Epidemiol 1996; 49:203-209.
5. Bauer KA. New markers for in vivo coagulation. Curr Opin Haematol 1994; 1:341-346.
6. 3 J, Paja̧k A, Undas A, Kawalec E, Topor-Madry R, Pazucha T, et al. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample. Thromb Haemost 1997; 77:697-700.
7. Hirsh J. Heparin. N Engl J Med 1991; 342:1565-1574.
8. Holgate ST. The role of mast cells and basophils in inflammation. Clin Exp Allergy 2000; (Suppl 1):28-32.
9. Laine P, Kaartinen M, Penttila A, Panula P, Paavonen T, Kovanen PT, et al. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 1999; 99:361-369.
10. Rosenberg R. Biochemistry of heparin anti-thrombin interaction and the physiologic role of this natural anticoagulant mechanism. Am J Med 1989; 87(Suppl 3B):2.
11. Szczeklik A, Dropiński J, Radwan J, Krzanowski M. Persistent generation of thrombin after acute myocardial infarction. Arteriosc Thromb 1992; 12:548-553.
12. Scharfstein JS, Abendschein DR, Eisenberg PR, George D, Cannon CP, Becker RC, et al. Usefulness of fibrinogenolytic and pro-coagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. Am J Cardiol 1996; 76:503-510.
13. Tanizaki Y, Sudo M, Ono H, Shioda Y, Matsuka Y, Tada S, et al. Plasma concentration of heparin and its metabolism in bronchial asthma. Jpn J Allergol 1983; 32:343-347.
14. Lasser D, Simon RA, Lyon SG, Hamblin AE, Stein R. Heparin-like anti-coagulants in asthma. Allergy 1987; 42:619-625.
15. Lasser EC, Berry C, Kortman K. Diminished atherosclerotic arterial calcifications in asthma. Allergy 1987; 47:549-552.
16. Rhatigan RM, Torre A. Myocardial necrosis and bronchial asthma. Ann Alergy 1970; 28:434-438.
17. Schoen SJ. Cardiac pathology in asthma. J Allergy Clin Immunol 1987; 80:419-423.
18. Metcalfe DD, Soter NA, Wasserman SI, Austen KF. Identification of sulphated mucopolysacharides including heparin in the lesional skin of a patient with mastocytosis. J Invest Dermatol 1980; 74:210-215.
19. Kauhanen P, Kovanen PT, Reunala T, Lassila R. Effects of skin mast cells on bleeding time and coagulation activation at the site of platelet plug formation. Thromb Haemost 1998; 79:843-847.
20. Valent P, Sillaber Ch, Baghestanian M, Bankl HC, Kiener HP, Lechner K, et al. What have mast cells to do with oedema formation, the consecutive repair, and fibrinolysis?. Int Arch Allergy Immunol 1998; 115:2-8.
21. Lewandowski K, Kulińska A, Zozulińska M, Zawilska K. Age-related changes in plasma endogenous heparin-like activity in healthy male volunteers. Thrombosis Research 1991; 62:109-114.